LAMISIL
Live / Registered — Registered and renewed (as of 12 May 2022)
What this means for you
Registered since 11 Dec 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Dec 2022).
Record
- Serial number
- 85528483
- Registration number
- 4256554
- Mark type
- Design + words
- Filed
- 30 Jan 2012
- Published for opposition
- 19 Jun 2012
- Registered
- 11 Dec 2012
- Next maintenance due
- 11 Dec 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely anti-fungal preparations
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 12 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 May 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 May 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jan 2022 — TEAS SECTION 8 & 9 RECEIVED
- 11 Dec 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Sept 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Sept 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Sept 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Aug 2018 — TEAS SECTION 8 & 15 RECEIVED
- 11 Dec 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Nov 2015 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Nov 2015 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Dec 2012 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2012 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED